Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04602546 · ClinicalTrials.gov registry record · NA

Evaluation of Bispectral Index (BIS™) and Levels of Sedation With Common Inhalational Anesthetics in Healthy Volunteers (OLIVER)

A NA study of Anesthesia, sponsored by Medtronic - MITG.

Completed
Registry status
NA
Development phase
211
Enrollment target
3
Study locations

NCT04602546 is a NA study of Anesthesia that has completed, run by Medtronic - MITG. The registered enrollment target is 211 participants, below the 109,407-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04602546, a NA study of Anesthesia, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
NA
Development phase
211 participants
Enrollment target
3
Study locations

Study Summary

To investigate the relationship between BIS™ and inhaled anesthetics across a wide range of anesthetic concentration and hypnotic states, and to provide evidence to support BIS™ performance in use with Isoflurane, Sevoflurane and Desflurane in combination with opioids.

Conditions Studied

Interventions

  • DEVICE BIS Complete Monitoring System

Study Locations (3)

California

  • University of California at San Francisco - San Francisco

North Carolina

  • Duke University Medical Center - Durham

Utah

  • University of Utah Health Science Center - Salt Lake City

Trial Details

FieldValue
Enrollment Target 211 participants
Start Date 2021-02-09
Est. Completion 2022-08-26
Phase NA

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT04602546

The ClinicalTrials.gov registry entry for NCT04602546 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,407-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which BIS Complete Monitoring System is the first listed.

NCT04602546 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, North Carolina, Utah.

Frequently Asked Questions

What is clinical trial NCT04602546 about?

NCT04602546 is a clinical study titled "Evaluation of Bispectral Index (BIS™) and Levels of Sedation With Common Inhalational Anesthetics in Healthy Volunteers (OLIVER)". To investigate the relationship between BIS™ and inhaled anesthetics across a wide range of anesthetic concentration and hypnotic states, and to provide evidence to support BIS™ performance in use with Isoflurane, Sevoflurane and Desflurane in combination with opioids.

What is the current status of trial NCT04602546?

This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2021-02-09. Estimated completion is 2022-08-26.

What conditions does trial NCT04602546 study?

This clinical trial studies the following conditions: Anesthesia.

What interventions are being tested in trial NCT04602546?

The interventions under investigation include: BIS Complete Monitoring System (DEVICE).

Who is sponsoring clinical trial NCT04602546?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04602546 being conducted?

This trial has 3 study locations across California, North Carolina, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.